Quantity size:
0.1ml
Concentration:
1mg/ml 磷酸化肿瘤抑制基因P53抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
p53 plays a major role in the cellular response to DNA damage and other genomic aberrations. The activation of p53 can lead to either cell cycle arrest and DNA repair, or apoptosis. p53 is phosphorylated at multiple sites in vivo and by several different protein kinases in vitro. p53 can apparently be phosphorylated by ATM, ATR, and DNAPK at Ser15; the phosphorylation impairs the ability of MDM2 to bind p53, promoting both the 磷酸化肿瘤抑制基因P53抗体accumulation and functional activation of p53 in response to DNA damage. Chk2 and Chk1 can phosphorylate p53 at Ser20, enhancing its tetramerization, stability and activity. p53 is phosphorylated at Ser392 in vivo and by CAK in vitro. Phosphorylation of p53 at Ser392 is altered in human tumors and has been reported to influence the growth suppressor function, DNA binding and transcriptional activation of p53. p53 is phosphorylated at Ser6 and Ser9 by ck1d and 磷酸化肿瘤抑制基因P53抗体ck1e both in vitro and in vivo. Phosphorylation of p53 at Ser46 is important in regulating the ability of p53 to induce apoptosis. In vivo phosphorylation of p53 at Ser33 by cdk7/cyclin H and in response to UV irradiation has been observed.
Also known as:
P53 (phospho S392); P53 (phospho Ser392); p-P53 (Ser392); p-P53 (S392); Widespread p53; Wtp53; Antigen NY-CO-13; Cellular tumor antigen p53; Cys 51 Stop; HGNC11998; LFS1; p53; p53 Cellular Tumor 磷酸化肿瘤抑制基因P53抗体Antigen; p53 Tumor Suppressor; Phosphoprotein p53; TP53; Transformation related protein 53; TRP53; Tumor protein p53; Tumour Protein p53; P53_HUMAN; TP53.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human p53 around the phosphorylation site of (Ser392).
●
Predicted Molecular Weight: 43kDa.
磷酸化肿瘤抑制基因P53抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl762Hu01叉头框蛋白O3(FOXO3)多克隆抗体Polyclonal Antibody to Forkhead Box Protein O3 (FOXO3)
kl762Mu01叉头框蛋白O3(FOXO3)多克隆抗体Polyclonal Antibody to Forkhead Box Protein O3 (FOXO3)
kl764Hu01叉头框蛋白O1(FOXO1)多克隆抗体Polyclonal Antibody to Forkhead Box Protein O1 (FOXO1)
kl766Hu01解整合素金属蛋白酶10(ADAM10)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloprotease 10 (ADAM10)
kl766Ra01解整合素金属蛋白酶10(ADAM10)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloprotease 10 (ADAM10)
kl768Hu01足盂蛋白(PCX)多克隆抗体Polyclonal Antibody to Podocalyxin (PCX)
kl768Mu01足盂蛋白(PCX)多克隆抗体Polyclonal Antibody to Podocalyxin (PCX)
kl770Hu01胱天蛋白酶5(CASP5)多克隆抗体Polyclonal Antibody to Caskle 5 (CASP5)
kl771Hu01趋化因子C-X-C-基元配体16(CXCL16)多克隆抗体Polyclonal Antibody to Chemokine C-X-C-Motif Ligand 16 (CXCL16)
kl771Ra01趋化因子C-X-C-基元配体16(CXCL16)多克隆抗体Polyclonal Antibody to Chemokine C-X-C-Motif Ligand 16 (CXCL16)
kl775Hu01己糖激酶1(HK1)多克隆抗体Polyclonal Antibody to Hexokinase 1 (HK1)
kl775Mu01己糖激酶1(HK1)多克隆抗体Polyclonal Antibody to Hexokinase 1 (HK1)
kl776Hu01丙酮酸脱氢酶α(PDHα)多克隆抗体Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl776Mu01丙酮酸脱氢酶α(PDHα)多克隆抗体Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl776Ra01丙酮酸脱氢酶α(PDHα)多克隆抗体Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl777Hu01T-细胞可诱导共刺激分子(ICOS)多克隆抗体Polyclonal Antibody to Inducible T-Cell Co Stimulator (ICOS)
kl778Hu01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Mu01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Po01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Ra01B-细胞淋巴瘤因子2(Bcl2)多克隆抗体Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl781Hu01CD276分子(CD276)多克隆抗体Polyclonal Antibody to Cluster Of Differentiation 276 (CD276)
kl782Ga01碳酸酐酶Ⅱ(CA2)多克隆抗体Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl782Hu01碳酸酐酶Ⅱ(CA2)多克隆抗体Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl783Hu01补体因子P(CFP)多克隆抗体Polyclonal Antibody to Complement Factor P (CFP)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话